Wen Bo Wang

Directeur/Membre du Conseil chez

Standards Coordinating Body

Health Technology

Consumer Services

Profil

Actuellement, Wen Bo Wang occupe le poste de vice-président principal des opérations techniques chez Fate Therapeutics, Inc. Le Dr Wang est également membre du conseil d'administration de l'organisme de coordination des normes. Auparavant, il a occupé le poste de directeur scientifique associé chez ViaCell, Inc. et celui de premier vice-président de la thérapie cellulaire chez FUJIFILM Cellular Dynamics, Inc. Le Dr Wang a obtenu un diplôme de premier cycle à l'Université océanique de Chine et un doctorat à l'Université de Newcastle.

Postes actifs de Wen Bo Wang

Sociétés	Poste	Début
Standards Coordinating Body Standards Coordinating Body The Standards Coordinating Body is a nonprofit organization focused on accelerating the development, awareness, and implementation of standards and best practices in regenerative medicine, including gene, cell, and advanced therapies. The private company is based in Gaithersburg, MD. It engages stakeholders such as government agencies, researchers, manufacturers, clinicians, and regulators to identify, prioritize, and advance standards that improve the safety, quality, efficacy, and availability of regenerative medicine products. The organization facilitates collaborative project working groups that develop feasibility studies, standards drafts, white papers, and coordinate data generation activities in areas like cell-based drug discovery, cell therapy, gene therapy, and tissue engineering. It offers specialized training programs on FDA-recognized ISO cell counting standards, including online and in-person courses, and provides resources such as an interactive database for exploring current and developing standards and educational materials.	Directeur/Membre du Conseil	-

Tous les postes actifs de Wen Bo Wang

Anciens postes connus de Wen Bo Wang

Sociétés	Poste	Fin
ViaCell, Inc. ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases	Corporate Officer/Principal	01/01/2005
CELLULAR DYNAMICS INTERNATIONAL INC	Corporate Officer/Principal	-
FATE THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	-

Voir l'expérience en détail de Wen Bo Wang

Formation de Wen Bo Wang

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Wen Bo Wang

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	6
ViaCell, Inc. ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases	Health Technology
Newcastle University Newcastle University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fate Therapeutics, Inc. Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company	Health Technology
FUJIFILM Cellular Dynamics, Inc. FUJIFILM Cellular Dynamics, Inc. BiotechnologyHealth Technology Manufactures human induced pluripotent stem cells (iPSCs) and iPSC-derived cells for drug discovery	Health Technology
Ocean University of China Ocean University of China Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Standards Coordinating Body Standards Coordinating Body The Standards Coordinating Body is a nonprofit organization focused on accelerating the development, awareness, and implementation of standards and best practices in regenerative medicine, including gene, cell, and advanced therapies. The private company is based in Gaithersburg, MD. It engages stakeholders such as government agencies, researchers, manufacturers, clinicians, and regulators to identify, prioritize, and advance standards that improve the safety, quality, efficacy, and availability of regenerative medicine products. The organization facilitates collaborative project working groups that develop feasibility studies, standards drafts, white papers, and coordinate data generation activities in areas like cell-based drug discovery, cell therapy, gene therapy, and tissue engineering. It offers specialized training programs on FDA-recognized ISO cell counting standards, including online and in-person courses, and provides resources such as an interactive database for exploring current and developing standards and educational materials.